In pre‐NAC samples, when comparing non‐responding to responding tumors in each subtype separately, inflammatory response‐related markers were significantly upregulated in luminal BC (ES >0.3, FDR <0.01) while being down‐regulated in HER2+ tumors (ES < −0.3, FDR <0.05). The gene discussed is ERBB2; the disease is breast cancer.